Works matching IS 03065251 AND DT 2012 AND VI 73 AND IP 6


Results: 29
    1

    Translation Section.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 1014, doi. 10.1111/j.1365-2125.2012.04306.x
    Publication type:
    Article
    2
    3

    Public understanding of drug therapy.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 943, doi. 10.1111/j.1365-2125.2012.04243.x
    By:
    • Herxheimer, Andrew
    Publication type:
    Article
    4
    5

    Medication errors.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 912, doi. 10.1111/j.1365-2125.2012.04236.x
    By:
    • Ferner, Robin E.
    Publication type:
    Article
    6

    Pharmacoeconomics.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 968, doi. 10.1111/j.1365-2125.2012.04247.x
    By:
    • Hughes, Dyfrig A.
    Publication type:
    Article
    7
    8
    9

    An Australian perspective.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 939, doi. 10.1111/j.1365-2125.2012.04242.x
    By:
    • Smith, Anthony J.
    Publication type:
    Article
    10
    11

    Adverse drug reactions.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 908, doi. 10.1111/j.1365-2125.2012.04235.x
    By:
    • Loke, Yoon K.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Crossing the fourth hurdle.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 855, doi. 10.1111/j.1365-2125.2012.04263.x
    By:
    • Rawlins, Michael D.
    Publication type:
    Article
    18
    19

    An agenda for UK clinical pharmacology.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 953, doi. 10.1111/j.1365-2125.2012.04245.x
    By:
    • Coleman, Jamie J.;
    • McDowell, Sarah E.
    Publication type:
    Article
    20
    21

    Research priorities in pharmacokinetics.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 924, doi. 10.1111/j.1365-2125.2012.04238.x
    By:
    • Tucker, Geoffrey T.
    Publication type:
    Article
    22

    Pharmacovigilance.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 979, doi. 10.1111/j.1365-2125.2012.04249.x
    By:
    • Edwards, I. Ralph
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Monitoring drug therapy.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 917, doi. 10.1111/j.1365-2125.2012.04237.x
    By:
    • Buclin, Thierry;
    • Gotta, Verena;
    • Fuchs, Aline;
    • Widmer, Nicolas;
    • Aronson, Jeffrey
    Publication type:
    Article
    29

    Pharmacoepidemiology.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 973, doi. 10.1111/j.1365-2125.2012.04248.x
    By:
    • Evans, Stephen J. W.
    Publication type:
    Article